Browsing: meeting

Kyowa Kirin International (KKI) has announced the upcoming presentation of interim findings from three significant real-world studies focusing on cutaneous T-cell lymphoma (CTCL) at the European Organisation for Research and Treatment of Cancer’s Cutaneous Lymphoma Tumour Group (EORTC-CLTG) annual meeting. The event is set to take place in Lausanne, Switzerland, from 9 to 11 October 2024. These studies involve participants from Europe, the United States, and the United Arab Emirates, and aim to gather evidence regarding the effectiveness of mogamulizumab, a pioneering humanised monoclonal antibody therapy. This treatment is currently approved in Europe and the UAE for adult patients with…

Endo, Inc. has unveiled new clinical data on collagenase clostridium histolyticum (CCH) for treating plantar fibromatosis at the American Orthopaedic Foot & Ankle Society’s (AOFAS) annual scientific meeting, which is being held through September 14, 2024. The Phase 2 clinical trial, presented orally at the conference, examined the efficacy of CCH in patients with plantar fibromatosis, also known as Ledderhose disease. The study, a double-blind, randomised, placebo-controlled trial, aimed to evaluate CCH’s impact compared to a placebo in alleviating the condition’s symptoms. Dr. James P. Tursi, Executive Vice President of Global Research & Development at Endo, emphasised the significance of…